Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 12, 2014 - Issue 2
Submit an article Journal homepage
2,636
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab

Joseph Adrian Lumawig BuensalidoDepartment of Internal Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI 48201, USACorrespondence[email protected]
&
Pranatharthi H ChandrasekarDepartment of Internal Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI 48201, USA
Pages 151-154 | Published online: 16 Dec 2013

References

  • Huang YH, Hsiao LT, Hong YC et al. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B. J. Clin. Oncol. 31(22), 2765–2772 (2013).
  • Griffin MM, Morley N. Rituximab in the treatment of non-Hodgkin’s lymphoma – a critical evaluation of randomized controlled trials. Expert Opin. Biol. Ther. 13(5), 803–811 (2013).
  • Yeo W, Chan TC, Leung NW et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitits B undergoing anticancer therapy with or without rituximab. J. Clin. Oncol. 27(4), 605–611 (2009).
  • Yeo W, Chan PK, Ho WM et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J. Clin. Oncol. 22(5), 927–934 (2004).
  • Weinbaum CM, Williams I, Mast EE et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm. Rep. 57(RR08), 1–20 (2008).
  • Artz SA, Somerfield MR, Feld JJ et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J. Clin. Oncol. 6(4), 193–194 (2010).
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B infection. J. Hepatol. 57(1), 167–185 (2012).
  • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 50(3), 661–662(2009).
  • Liu CY, Chandrasekar PH, Masood A, Schiffer CA. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation. J. Oncol. Pharm. Pract. 19(1), 18–23 (2013).
  • Hui CK, Cheung WW, Zhang HY et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131(1), 59–68 (2006).
  • Matsue K, Kimura S, Takanashi Y et al. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer 116(20), 4769–4776 (2010).
  • Targhetta C, Cabras MG, Mamusa AM et al. Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica 93, 951–952 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.